JBRF Board of Directors


Charles Goldberg, Director of Development

Mr. Goldberg’s professional background includes over 30 years of commercial real estate experience in New York City.  He is a Senior Managing Director at Colliers International.  He is a graduate of Phillips Exeter Academy, earned an A.B. in Politics from Princeton University and attended New York University School of Business. Additionally, Mr. Goldberg has attended the New York University Real Estate Institute. As an active member of the community, Mr. Goldberg is belongs to numerous professional and civic organizations. He is a member of the Board of Directors of Cultural Crossovers, an organization which curates cultural exhibits to youth worldwide within the context of children’s museums, a former board member of PASE, The Partnership for After School Education and Director of Development for the Juvenile Bipolar Research Foundation. With strong alumni ties, Mr. Goldberg is past President of The Phillips Exeter Academy General Alumni/ae Association of New York and is involved in fundraising efforts at Princeton University. He is a long-standing member of the Real Estate Board of New York (REBNY) and participates in a variety of community-based youth development programs in his hometown of Bronxville, New York.

 


Dr. Herbert M. Lachman

Dr. Lachman is a professor in the Department of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine. He also holds joint appointments in the departments of Medicine, Genetics and Neuroscience. Dr. Lachman became of a member of the JBRF Board of Directors in 2011. He is a co-author of 90 scientific papers, book chapters and reviews. He has also written a book for laymen exploring the role of Darwinian selection in human disease called, “Battle of the Genomes: The Struggle For Survival in a Microbial World.” Dr. Lachman’s primary research interests are the molecular and genetic basis of bipolar disorder and schizophrenia, and the development of patient-specific induced pluripotent stem cell (iPSC) technology to model neuropsychiatric disorders in the laboratory. iPSCs are derived from skin cells and can be turned into human neurons, which can then be studied in animal-free systems. iPSC technology is a very promising tool for developing new drugs for neuropsychiatric disorders. In addition to research, Dr. Lachman sees patients in the Division of Substance Abuse and is very involved in student education at Einstein where he teaches human genetics to first year medical students, and graduate students in the Sue Golding Graduate Division and Clinical Research Training Program. He has received two teaching awards at Einstein. He is also a grand rounds speaker and gives a lecture on the role of genes in criminal behavior at Fordham Law School.

Dr. Lachman is board certified in Internal Medicine and is a member of the American Association for the Advancement of Science and the International Society of Psychiatric Genetics. He is an editor for the Open Psychiatry Journal and the Frontiers in Behavioral Neuroscience and has reviewed papers for some of the top psychiatry and neuroscience journals, including Molecular Psychiatry, Biological Psychiatry, American Journal of Medical Genetics, Human Molecular Genetics and the Archives of General Psychiatry. He has also reviewed grants for 20 NIH study sections. Dr. Lachman lives in Manhattan with his wife and two children.

 

Dr. Steven Mattis

 

%d bloggers like this: